Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 3/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.51 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13264797 | 0.94 | MAPT (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4389151 | 0.94 | CES2 (0.54) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4389147 | 0.94 | CES2 (0.54) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL13236826 | 0.89 | ALDH1A1 (0.47) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL13236835 | 0.89 | CYP1A1 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL11891940 | 0.85 | ALDH1A1 (0.54) | MAPTALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL11296722 | 0.85 | ALDH1A1 (0.54) | MAPTALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL11296725 | 0.85 | ALDH1A1 (0.54) | MAPTALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL2207899 | 0.85 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL2207897 | 0.85 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2847784-B1 | POLISHING PAD WITH LIGHT-STABLE LIGHT-TRANSMITTING REGION | CABOT MICROELECTRONICS CORP (US) | 2017-07-05 | — | — | EP | claimed |
| US-9156125-B2 | Polishing pad with light-stable light-transmitting region | CABOT MICROELECTRONICS CORPORATION (US) | 2015-10-13 | — | — | US | claimed |
| US-20130273813-A1 | POLISHING PAD WITH LIGHT-STABLE LIGHT-TRANSMITTING REGION | CABOT MICROELECTRONICS CORPORATION (US) | 2013-10-17 | — | — | US | claimed |
| EP-1100447-B1 | SUNSCREEN COMPOSITIONS | PROCTER & GAMBLE (US) | 2004-05-12 | — | — | EP | claimed |
| EP-1100447-A1 | SUNSCREEN COMPOSITIONS | The Procter & Gamble Company (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2000006110-A1 | SUNSCREEN COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-10 | — | — | WO | claimed |
| US-5989528-A | Sunscreen compositions | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-23 | — | — | US | claimed |
| US-5587150-A | Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate | L'OREAL (FR) | 1996-12-24 | — | — | US | claimed |
| US-5576354-A | Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate | L'OREAL (FR) | 1996-11-19 | — | — | US | claimed |
| EP-0514491-B1 | LIGHT-RESISTANT FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND AN ALKYL BETA, BETA-DIPHENYLACRYLATE OR AN ALKYL ALPHA-CYANO-BETA, BETA-DIPHENYLACRYLATE | OREAL (FR) | 1993-11-03 | — | — | EP | claimed |
| EP-3134499-B1 | CLEANING FORMULATIONS FOR CHEMICALLY SENSITIVE INDIVIDUALS: COMPOSITIONS AND METHODS | VAN BUSKIRK GREGORY (US) | 2025-01-29 | — | — | EP | disclosed |
| US-20240254411-A1 | Alkyl Polyglycoside-Containing Cleaning Formulations for Chemically Sensitive Individuals | SENSITIVE HOME, INC. (US) | 2024-08-01 | — | — | US | disclosed |
| US-12004630-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-06-11 | — | — | US | disclosed |
| US-11998104-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-06-04 | — | — | US | disclosed |
| US-11980277-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-05-14 | — | — | US | disclosed |
| US-5556852-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0395446-B1 | N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists | SANKYO CO (JP) | 1995-03-01 | — | — | EP | disclosed |
| US-5369106-A | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists | SANKYO COMPANY, LIMITED (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5192766-A | Platelet activating factor antagonist | SANKYO COMPANY, LIMITED (JP) | 1993-03-09 | — | — | US | disclosed |
| EP-0395446-A2 | N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists | Sankyo Company Limited (JP) | 1990-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11980277-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | HDAC3 4639/4885HDAC4 2232/4885HDAC1 3648/4885 |
| US-11998104-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | HDAC3 4639/4885HDAC4 2232/4885HDAC1 3648/4885 |
| US-12004630-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | HDAC3 4639/4885HDAC4 2232/4885HDAC1 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.